Czech/SlovakiaCzech RepublicSlovakia

National platform to boost industrial biotechnology

16.07.2008

Brno – Czech biotechnologists and EU industry experts have worked out an action plan to improve the development of industrial biotechnology in the Czech Republic. The recommendations are based on three SWOT analyses (R&D, Innovation, and Policy) that monitor the current development stage of industrial biotechnology worked out at a two day roundtable that brought together Czech biotech experts with representatives from EuropaBio, SusChem, the EU-tech platform for sustainable chemistry, and the European Commission in Brno.

Enabling better tech transfer

“The Czech Republic had a great past in traditional biotechnology – in fermentation, continuous culture, or biotransformations. And it pioneered antibiotic production,” summarised Dr. Peter Sebo, biotechnologist at the Czech Academy of Sciences in Prague. “But currently, there are several bottlenecks that hamper the development of modern biotechnology.” Only four out of 42 modern biotech companies (Lonza, Baxter, Comtipor, ExBio) located in the Czech Republic are currently active in industrial biotech. Sebo estimates the industry in the Czech Republic as a whole employs about 2,000 staff and has turnover of roughly EUR200m per year, but added that there is limited R&D in advanced biotech, almost no biotech IP and thus no venture capital available. Nevertheless, he remained optimistic about the future. An Institute of Biotechnology was founded this January, while a biotech and biomed research centre called BIOCEV, which by 2012 will provide labs for 450 researchers and 150 students, is being built up in Prague. Last but not least, the government has established long term funding schemes for biotechnology. “Currently we have more funding than biotech people,” said Sebo.
On a national scale, the experts called for a specific funding program for white biotech that links national participants from industry and research, as well as for the launch of an awareness campaign for communicating the advantages of White Biotech to politicians and the public. They also re­commended improving technology transfer from research to industry, and educational programs to address the lack of managerial skills among researchers. Finally, they concluded that the construction of an open production plant would give Czech biotech companies the opportunity to test large-scale production without having to build costly production facilities on their own.
At the European level, they asked for a harmonisation of IP rights, additional funding for basic research projects, less bureaucracy, and the establishment of a European seed funding programme.
“The meeting has helped to better inform the Commission about industrial biotech, and map the possibility of further financial support tailored to the Czech specific situation,” said Michal Kostka, Deputy Director of the South Moravian Innovation Centre. The round table was the first in a series of meetings in which SusChem will be assessing White Biotech activities in eight Eastern EU member states.


Czech/SlovakiaCzech RepublicSlovakia

01.02.2010

Prague – After increasing its investment in mid-January, full-service provider CRO FGK Clinical Research GmbH has become a major shareholder in the Czech contract research organization Avemedica s.r.o. Financial details were not...

Czech/SlovakiaCzech RepublicSlovakia

01.02.2010

Pilzen – German antibody drug development and discovery firm Affimed Therapeutics AG (Heidelberg) has spun-out all of its antibody discovery activities into a new Czech subsidiary – AbCheck s.r.o., which is located in Pilzen....

Czech/SlovakiaCzech RepublicSlovakia

18.09.2009

Prague/Jena – German and Czech researchers under Ales Svatos have opened the door to major improvements in the application of high-throughput metabolomics and systematic analyses of small molecules via MALDI-mass spectrometry...

Czech/SlovakiaCzech RepublicSlovakia

19.07.2009

Ceské Budejovice - The scientists from the Biology Centre of the Czech Academy of Science who coordinated the EU project MOBITAG have tabled a report on their attitudes towards political interference in the EU’s GMO authorisation...

Czech/SlovakiaCzech RepublicSlovakia

14.07.2009

Bratislava – According to a new study released by PG Economics, Slovak farmers would benefit more than counterparts in other EU countries from planting genetically-engineered Bt maize. Regional factors, as well as reducing an...

Czech/SlovakiaCzech RepublicSlovakia

14.07.2009

Vestec – The Czech Academy of Sciences and Charles University plan to build a modern biotechnology and biomedicine center, according to reports issued by the Czech Information Agency. With about 40,000 square meters of floor...

Czech/SlovakiaCzech RepublicSlovakia

13.07.2009

Olomouc – A new cluster with a focus on drug development and diagnostics has been established near Palacky University in Olmouc. Called MedChemBio, the centre seeks to attract companies with an interest in medicinal and...

Czech/SlovakiaCzech RepublicSlovakia

12.07.2009

Prague – A biotech company and a pharmaceutical enterprise are the winners of this year’s “Investor of the Year” competition, which is organised by CzechInvest and the country’s Association for Foreign Investment. At the end of...

Czech/SlovakiaCzech RepublicSlovakia

29.04.2009

Prague – A2Z Bio, the Czech subsidiary of UK-based Yorkshire Bioscience, is investing EUR100,000 at the CKD Prague Technological Innovation Centre to launch production of research reagents and services for the biotech R&D market....

Displaying results 11 to 20 out of 70

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-czech-slovakia/browse/1/article/national-platform-to-boost-industrial-biotechnology.html

Product of the week

Products

Events

All Events

Current issue

All issues